Fresenius Medical Care AG & Co KGaA
F:FMEA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fresenius Medical Care AG & Co KGaA
F:FMEA
|
DE |
|
M
|
Marathon Digital Holdings Inc
F:M44
|
US |
Intrinsic Value
The intrinsic value of Fresenius Medical Care AG & Co KGaA (FMEA) under the Base Case is 39.24 EUR per share. Compared with the current market price of 20.4 EUR, the stock appears Undervalued by 48% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Fresenius Medical Care AG & Co KGaA Does
Fresenius Medical Care is a kidney care company. It runs dialysis clinics where patients with kidney failure receive regular treatment, and it also makes and sells the dialysis machines, filters, and related supplies used in those treatments. Its business sits at the center of chronic kidney care, serving both patients directly and the healthcare providers that treat them.
- Headquarters
- Germany DE
- Employees
- 122 909
- IPO date
- Oct 2, 1996
Fresenius Medical Care AG & Co KGaA has no economic moat
Patients and healthcare buyers can choose among several dialysis providers and equipment makers; more people using Fresenius does not, by itself, make its services more valuable to other patients. Its size has not made it the sole or unavoidable provider in the markets it serves.
Read the full moat analysis
Revenue & Expenses Breakdown
Fresenius Medical Care AG & Co KGaA
Earnings Waterfall
Fresenius Medical Care AG & Co KGaA
The intrinsic value for Fresenius Medical Care AG & Co KGaA (FMEA) under the Base Case is 39.24 EUR.
Compared with the current market price of 20.4 EUR, the stock appears Undervalued by 48% .